IMPORTANT INFORMATION

  • CFTR.info is an online educational resource on the genetics of cystic fibrosis (CF) and the role of CF transmembrane conductance regulator (CFTR) in normal human physiology as well as in CF.
  • The information contained herein is intended for healthcare professionals working within the European Union (EU).
  • The content of this website has been developed independently by a group of CF healthcare professionals and is for general information purposes only.
  • All of the information about CFTR and CFTR modulators has been obtained from referenced sources and is in the public domain.
  • This website is not intended to promote or advocate a particular course of treatment or any specific drug, whether licensed or unlicensed, nor is it intended to imply or suggest that any drug be used for any purpose other than that which for which it is licensed in the EU.

ABBREVIATED TERMS & CONDITIONS

  • While we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information and related graphics, or products and treatments, contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
  • In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from, or in connection with, the use of this website.
  • Through this website you are able to link to other websites which are not under our control. We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
  • Every effort is made to keep the website up and running smoothly. However, we take no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.

Please see the full Terms & Conditions before using this website.

 

I have read and understood the above

Drug & research development » Clinical Trials

Filter Trials

Intervention

Location

Study phase

Number of patients

Patients Age

Trial type

Trial No.
Intervention
NCT00004779
Ad5-CB-CFTR, Genetic
NCT00458341
Ataluren
NCT01140451
Ataluren
NCT00803205
Ataluren
NCT02139306
Ataluren
NCT02107859
Ataluren
NCT00234663
Ataluren
NCT00351078
Ataluren
NCT00237380
Ataluren
NCT00004471
Genetic
NCT00004806
Genetic
NCT01937325
Genetic, H5.001CBCFTR
NCT02190604
Genetic, QBW251
NCT01621867
Genetic, pGM169/GL67A
NCT00073463
Genetic, tgAAVCF
NCT01262352
Ivacaftor
NCT01614457
Ivacaftor
NCT00909727
Ivacaftor
NCT00909532
Ivacaftor
NCT01117012
Ivacaftor
NCT02194881
Ivacaftor
NCT01208285
Ivacaftor
NCT01705145
Ivacaftor
NCT00953706
Ivacaftor
NCT02310789
Ivacaftor
NCT01863238
Ivacaftor
NCT01060566
Ivacaftor
NCT01614470
Ivacaftor
NCT01549314
Ivacaftor
NCT02141464
Ivacaftor
NCT00457821
Ivacaftor
NCT01161537
Ivacaftor
NCT01685801
Ivacaftor
NCT01784419
Ivacaftor
NCT01707290
Ivacaftor
NCT01946412
Ivacaftor
NCT01381289
Ivacaftor
NCT02039986
Ivacaftor
NCT01937325
Ivacaftor
NCT01153542
Ivacaftor
NCT00966602
Ivacaftor, Lumacaftor
NCT01931839
Ivacaftor, Lumacaftor
NCT01807949
Ivacaftor, Lumacaftor
NCT01216046
Ivacaftor, Lumacaftor
NCT01899105
Ivacaftor, Lumacaftor
NCT01897233
Ivacaftor, Lumacaftor
NCT01807923
Ivacaftor, Lumacaftor
NCT01225211
Ivacaftor, Lumacaftor
NCT01910415
Ivacaftor, Lumacaftor, moxifloxacin hydrochloride
NCT01531673
Ivacaftor, VX-661
NCT02347657
Ivacaftor, VX-661
NCT02070744
Ivacaftor, VX-661
NCT02015507
Ivacaftor, VX-661, ciprofloxacin
NCT01018368
Ivacaftor, rifampin
NCT00865904
Lumacaftor
NCT01339897
N6022
NCT01746784
N6022
NCT01147406
N6022
NCT02013388
N91115
NCT02275936
N91115
NCT02227888
N91115
NCT00659529
Sildenafil
NCT02057458
Sildenafil
NCT01768663
ciprofloxacin, Ivacaftor, Lumacaftor, itraconazole, rifampin